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Abstract
Predicting the release performance of a drug delivery device is an important challenge in
pharmaceutics and biomedical science. In this paper, we consider a multi-layer diffusion model
of drug release from a composite spherical microcapsule into an external surrounding medium.
Based on this model, we present two approaches that provide useful indicators of the release
time, i.e. the time required for the drug-filled capsule to be depleted. Both approaches make use
of temporal moments of the drug concentration versus time curve at the centre of the capsule,
which provide useful insight into the timescale of the process and can be computed exactly
without explicit calculation of the full transient solution of the multi-layer diffusion model. The
first approach, which uses the zeroth and first temporal moments only, provides simple algebraic
expressions involving the various parameters in the model (e.g. layer diffusivities, mass transfer
coefficients, partition coefficients) to characterize the release time while the second approach
yields an asymptotic estimate of the release time that depends on consecutive higher moments.
Through several test cases, we show that both approaches provide a computationally-cheap
and useful measure to compare a priori the release time of different composite microcapsule
configurations.
Keywords: mass diffusion, drug release, release time, composite capsule, asymptotic estimates.
1 Introduction
Polymeric microcapsules are commonly used in pharmaceutical or medical processes as drug carriers
or for the encapsulation of organic cells [1, 2]. The main functions of these micro- or nano-sized
vesicles are the efficient transport and controlled release of the therapeutic agent into the external
environment. Typically, drug-filled microcapsules exhibit a multi-layered structure consisting of a
spherical core surrounded by a thin, protective semi-permeable polymeric shell. The release prop-
erties depend crucially on the nature of this coating structure [3]. For this reason, in recent years,
materials innovation and nanotechnology have stimulated novel research and progress in biodegrad-
able, biocompatible, environment-responsive, and targeted delivery systems [4, 5]. Mathematical
modeling plays an important role in elucidating the drug release mechanisms, thus facilitating the
development of advanced materials and the assessment of smart products by a systematic, rather
than trial-and-error, approach. Within this area, special attention is given to semi-empirical and
mechanistic models, which often provide a good fit with experimental data [6, 7].
Analysis and solution of mechanistic models taking into account the multi-layer structure of the
microcapsule has been recently addressed by Kaoui et al. [8] and Carr and Pontrelli [9]. However,
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even in situations where the transport phenomena are well represented mathematically, the need
exists to develop analytical tools or simple indicators to extract meaning from the model and the
data. Such tools make it possible to answer practical questions, such as how long it takes to attain
a therapeutic flux, or what processing conditions need to be adjusted and by how much, in order to
reach a desired delivery rate without solving the complete mechanistic model. Furthermore, when
a full mathematical representation is not available, or is too complicated to be of any practical use,
simple performance indicators are required to elucidate the main transport mechanisms and identify
the most critical components of the process. In most circumstances, for example, rather than the
full transient solution, the time required to reach a steady state plasma drug concentration solely
determines the effectiveness of the delivery system.
Among several mathematical techniques available for control systems analysis, Laplace transform
and linearization techniques are frequently applied to describe a process’ dynamics through an
effective time constant [10]: this represents a useful indicator of the time elapsed before reaching a
steady state. The concept of a time constant is crucial to pharmaceutical developers who want to
create controlled-release devices able to deliver drugs at a desired rate. Estimation of the release
time, i.e. the time required for the drug-filled capsule to be depleted, is of great importance in the
design of drug delivery systems, because it allows product manufacturers to tune specific properties
to ensure a precise release within a determined time [11]. The idea of using a single timescale to
characterize how fast the drug concentration reaches the equilibrium value has been explored by
several authors. Pontrelli and Simon [12] define a timescale equal to the mean of a normalized
probability density function representing the transition of the concentration profile from initial
to equilibrium state. Calculating this mean requires either computing the full transient solution
or evaluating the Laplace transform of the transient solution, and ultimately for multi-layered
problems, produces quite complex expressions for the timescale in terms of the relevant parameters
in the model. Another approach is the concept of mean action time, which has been used to
characterize how long a diffusion process takes to reach steady state [13–16]. Here, the transition
from initial to equilibrium state is represented as a cumulative distribution function, with the
mean of the corresponding probability density function defining the characteristic timescale. The
attraction of the mean action time is that it completely avoids any calculation of the transient
solution and produces simple explicit algebraic formulas for the timescale in terms of the parameters
in the model [14, 15]. Finally, we note that the notion of release time is different but related to the
concept of penetration time, which that has been studied in a number of configurations for thermal
disturbances in heat conduction problems [17].
In this paper, inspired by recent literature on diffusion processes [14, 15, 18–20], we present
two approaches that provide useful indicators of the release time for a drug-filled capsule. Both
approaches utilize temporal moments of the concentration versus time curve at the centre of the
capsule. The first approach, which uses the zeroth and first moments only, provides a simple and
cheap way to characterize the release time in terms of the various parameters in the model (e.g.
layered diffusivities, mass transfer coefficients, partition coefficients). The second approach yields
an asymptotic estimate of the release time, defined as the time when the drug concentration at the
centre of the capsule is a small prescribed distance away from its steady-state value. Attractively,
both approaches can be used to avoid explicit (analytical or numerical) solution of the mathematical
model and are useful to compare a priori different capsule configurations.
The remaining parts of this article are ordered in the following way: (i) the diffusion model
for drug release from a spherical multi-layer capsule is presented (ii) both approaches for providing
indicators of the release time are described (iii) a specific case study on a core-shell capsule is
considered and numerical results presented and discussed.
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Figure 1: Schematic representation of the cross-section of the radially symmetric capsule, comprising an internal core
Ω0 (0 < r < R0), a concentric layer Ω1 (R0 < r < R1) and the thin coating shell (in red). This two-layer sphere is
immersed in the release medium, represented by a concentric external layer Ωe, delimited by the dashed line R∞. The
length R∞ is named release distance and is defined as the minimum distance from the sphere surface beyond which
c(x, t) ' 0, within a prescribed tolerance, at all times. This three enveloped layer system constitutes the object of our
modelling (figure not to scale).
2 Drug diffusion model for a multi-layer sphere
Multi-layer capsules consist of a drug-loaded (fluid or solid) spherical core surrounded by one or
more polymeric layers [1, 2]. Such layer-by-layer assembly enhances a selective diffusion and allows
for better control of the transfer rate. In this framework, and in the most general case of n layers,
the composite system can be treated as a sequence of enveloping concentric shells, constituted by
spheres of increasing radii satisfying 0 < R0 < R1 < . . . < Rn (see Figure 1 for the case n = 1).
To prevent fast delivery, the capsule’s outmost layer is protected with a thin semi-permeable shell
(coating). This coating shields and preserves the encapsulated drug from degradation and chemical
aggression, protects the inner structure, and guarantees a more controlled and sustained release [21].
The coating is in contact with the targeted external release medium (either a bulk fluid or a tissue).
Strictly speaking, for a pure diffusion problem into a homogeneous medium, the concentration field
undergoes an exponential decay and vanishes asymptotically at infinite distance. In other words,
at a given time, the concentration is gradually damped, reaching zero at infinite distance [22].
Nevertheless, for computational purposes, we can confine the diffusion process within an enveloping
spherical layer of finite extent, at a distance “far enough” from the capsule surface. In our model,
this additional layer is defined by setting a cut-off length R∞  Rn (sometimes named release
distance or diffusion length), beyond which the concentration reduces to zero, within a prescribed
tolerance, at all times (Figure 1) [23]:
c(x, t) ' 0 for all x ≥ R∞ and t > 0.
Due to homogeneity and isotropy, we can assume that net drug diffusion occurs along the radial
direction only, and thus we restrict our study to a one-dimensional model (Figure 1) that reflects a
perfectly radially symmetric system. We adopt the model formulated in [8, 9], where the evolution
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of concentrations in the layers is governed by a set of one-dimensional linear diffusion equations:
∂c0
∂t
=
D0
r2
∂
∂r
(
r2
∂c0
∂r
)
, r ∈ (0, R0), (2.1)
∂ci
∂t
=
Di
r2
∂
∂r
(
r2
∂ci
∂r
)
, r ∈ (Ri−1, Ri) for i = 1, . . . , n, (2.2)
∂ce
∂t
=
De
r2
∂
∂r
(
r2
∂ce
∂r
)
, r ∈ (Rn, R∞), (2.3)
paired with interlayer and boundary conditions
∂c0
∂r
= 0, r = 0, (2.4)
ci = σici+1, Di
∂ci
∂r
= Di+1
∂ci+1
∂r
, r = Ri for i = 1, . . . , n− 1, (2.5)
Dn
∂cn
∂r
= De
∂ce
∂r
, De
∂ce
∂r
= P (σnce − cn), r = Rn, (2.6)
ce = 0, r = R∞. (2.7)
In the above equations, the parameters Di are the diffusion coefficients of drug in each layer, σi are
the partition coefficients, and P is the mass transfer coefficient at the external coating [8, 9]. For a
releasing drug-loaded core, the initial conditions are:
c0(r, 0) = C0, r ∈ (0, R0), (2.8)
ci(r, 0) = 0, r ∈ (Ri−1, Ri) for i = 1, . . . , n, (2.9)
ce(r, 0) = 0, r ∈ (Rn, R∞), (2.10)
where C0 > 0 is a constant. The steady state solution of the drug diffusion model (2.1)–(2.10) is
trivially given by
c∞i (r) = lim
t→∞ ci(r) = 0, for i = 0, 1, . . . , n, e. (2.11)
In our previous studies the transient solution of Eqs (2.1)–(2.10) was obtained through a sepa-
ration of variables [8], or a Laplace transform approach [9]. In some circumstances, however, rather
than working with the complicated expressions of the full solution, simple and cheap measures of the
performance of the delivery system are desired. In the following sections, we propose two ways to
quantify the release time of the microcapsule, that is, the time taken for the capsule to be depleted
of the drug.
3 Characterizing the release time
In this section, we define two indicators that provide a useful characterisation of the release time
scale. Figure 2 shows the typical spatio-temporal behaviour of the dimensionless concentration,
ci(r, t)/C0, arising from the solution of the diffusion model (2.1)–(2.10). An important observation
from this plot is that the centre of the capsule, r = 0, takes the longest time to reach steady state. In
Figure 2b we plot the dimensionless concentration at the centre of the capsule, c˜0(t) := c0(0, t)/C0,
versus time as it progresses towards the steady state solution of zero concentration (2.11). The area
underneath the curve c˜0(t), or the zeroth temporal moment of c˜0(t), is defined as
t(1)c =
∫ ∞
0
c˜0(t) dt, (3.1)
4
and shaded in Figure 2b. The value of t
(1)
c will tend to be small for a fast release and large for a
slow release. Moreover, when comparing two different capsule configurations, if the corresponding
c˜0(t) curves for the two configurations do not intersect then the configuration with the larger release
time will have a larger area (larger value of t
(1)
c ). Therefore, it is reasonable to conclude that t
(1)
c
provides a useful characterization of the timescale of release1.
0
0
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Figure 2: Typical spatio-temporal behaviour of the drug concentration arising from the drug diffusion model (2.1)–
(2.10) with a single hydrogel layer (n = 1) (a) Plot of the dimensionless concentration (ci(r, t)/C0) versus radius (r)
at four values of t with a black arrow indicating the direction of increasing time. Vertical lines denote the interfaces
r = R0 and r = R1. (b) Plot of the dimensionless concentration at the centre of the capsule c˜0(t) versus time. The
area underneath this curve defines the characteristic timescale t
(1)
c (3.1) while the release time, as defined in Section
4, is the time when c˜0(t) reaches a small prescribed value ε.
A major attraction of working with Eq (3.1) is that a simple closed-form expression can be
derived for t
(1)
c involving the model parameters without requiring the full expression for c0(0, t).
This is achieved by extending and modifying similar ideas presented elsewhere (see, e.g., [14, 15]).
First, we define:
ui(r) =
1
C0
∫ ∞
0
ci(r, t) dt, (3.2)
which allow us to write down an equivalent form of Eq (3.1)
t(1)c = u0(0). (3.3)
Next, applying the linear operator L, defined as
Lϕ := Di
r2
d
dr
(
r2
dϕ
dr
)
, (3.4)
to both sides of Eq (3.2) and making use of Eqs (2.1)–(2.3) yields the following differential equation:
Di
r2
d
dr
(
r2
dui
dr
)
=
1
C0
[
c∞i (r)− ci(r, 0)
]
. (3.5)
Supplementary boundary and interlayer conditions corresponding to Eqs (2.4)–(2.7) are derived
using the definition of ui(r) in Eq (3.2) (see, e.g. [14, 18]). In summary, recalling the initial
1We remark that Eq (3.1) differs from the standard definition of mean action time (see e.g. [14]) commonly used
to characterize the time taken for a diffusion process to reach steady state. The reason for this difference is that the
standard definition is not defined when ci(r, 0) = c
∞
i (r), as is the case in Eqs (2.8)–(2.11).
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conditions (2.8)–(2.10) and the steady-state solution (2.11), we have the following boundary value
problem satisfied by ui(r) (i = 0, 1, . . . , n, e):
D0
r2
d
dr
(
r2
du0
dr
)
= −1, r ∈ (0, R0) (3.6)
Di
r2
d
dr
(
r2
dui
dr
)
= 0, r ∈ (Ri−1, Ri) for i = 1, . . . , n, (3.7)
De
r2
d
dr
(
r2
due
dr
)
= 0, r ∈ (Rn, R∞), (3.8)
du0
dr
= 0, r = 0, (3.9)
ui = σiui+1, Di
dui
dr
= Di+1
dui+1
dr
, r = Ri for i = 0, 1, . . . , n− 1, (3.10)
Dn
dun
dr
= De
due
dr
, De
due
dr
= P (σnue − un), r = Rn, (3.11)
ue = 0, r = R∞. (3.12)
The above boundary value problem admits a closed-form analytical solution. By way of example,
we consider the simplest case of the core-shell model, a drug-filled core surrounded by one hydrogel
shell (n = 1). In this case, the differential equations (3.6)–(3.8) possess the general solution:
u0(r) =
α0
r
+ α1 − r
2
6D0
, (3.13)
u1(r) =
α2
r
+ α3, (3.14)
ue(r) =
α4
r
+ α5, (3.15)
where α0, α1, . . . , α5 are arbitrary constants. Immediately, the boundary condition (3.9) requires
α0 = 0. The remaining constants satisfy the following algebraic system generated by substituting
Eqs (3.13)–(3.15) into the four interface conditions (3.10)–(3.11) with n = 1:
α1 − R
2
0
6D0
= σ0
(
α2
R0
+ α3
)
, (3.16)
R0
3
=
D1α2
R20
, (3.17)
D1α2
R21
=
Deα4
R21
, (3.18)
− Deα4
R21P
= σ1
(
α4
R1
+ α5
)
− α2
R1
− α3, (3.19)
α4
R∞
+ α5 = 0. (3.20)
Eqs (3.16)–(3.20) can then be solved sequentially: Eq (3.17) for α2, Eq (3.18) for α4, Eq (3.20) for
α5, Eq (3.19) for α3 and finally Eq (3.16) for α1. Combining these results with Eqs (3.13)–(3.15)
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yields the solution to the boundary value problem (3.6)–(3.12)2:
u0(r) =
R20 − r2
6D0
+
σ0R
2
0(R1 −R0)
3D1R1
+
σ0σ1R
3
0(R∞ −R1)
3DeR1R∞
+
σ0R
3
0
3R21P
, r ∈ (0, R0), (3.21)
u1(r) =
R30(r −R1)
3D1R1r
+
σ1R
3
0(R∞ −R1)
3DeR1R∞
+
R30
3R21P
, r ∈ (R0, R1), (3.22)
ue(r) =
R30(R∞ − r)
3DeR∞r
, r ∈ (R1, R∞). (3.23)
Evaluating Eq (3.21) at r = 0 gives the following expression for the characteristic timescale (3.3):
t(1)c =
R20
6D0
+
σ0R
2
0 (R1 −R0)
3D1R1
+
σ0σ1R
3
0 (R∞ −R1)
3DeR1R∞
+
σ0R
3
0
3R21P
. (3.24)
In summary, Eq (3.24) provides a simple formula for characterizing the timescale of release: for
small values of t
(1)
c we expect a rapid release while for large values of t
(1)
c we expect a slow release
[14].
An alternative to t
(1)
c is to incorporate the first temporal moment,
∫∞
0 tc˜0(t) dt, into the calcu-
lation [15]:
t(2)c =
∫ ∞
0
c˜0(t) dt+
√∫ ∞
0
tc˜0(t) dt = t
(1)
c +
√∫ ∞
0
tc˜0(t) dt, (3.25)
where the square root ensures that the second term has units of time. Note that t
(2)
c > t
(1)
c with
the inclusion of this additional term in Eq (3.25) introducing a penalty to c˜0(t) curves with heavy
tails that exhibit a slower decay to zero, behaviour that may not be captured by the zeroth moment
alone. By deriving a similar boundary value problem to Eqs (3.6)–(3.12) for the first moment, as
described later in Section 4, the following closed-form expression can be derived:
t(2)c =
R20
6D0
+
σ0R
2
0 (R1 −R0)
3D1R1
+
σ0σ1R
3
0 (R∞ −R1)
3DeR1R∞
+
σ0R
3
0
3R21P
+
{
7R40
180D20
+
7σ0R
4
0(R1 −R0)
45D0D1R1
+
7σ0σ1R
5
0(R∞ −R1)
45D0DeR1R∞
+
7σ0R
5
0
45D0PR21
+
2σ0R
3
0(R1 −R0)2(σ0R0 +R1 −R0)
9D21R
2
1
+
4σ0σ1R
3
0(R∞ −R1)(σ0R30 −R30 +R31)
9DePR31R∞
+
2σ0R
3
0(R1 −R0)(2σ0R20 − 2R20 +R0R1 +R21)
9D1R21
[
σ1(R∞ −R1)
DeR∞
+
1
PR1
]
+
2σ0σ1R
3
0(R∞ −R1)2(σ0σ1R30 − σ1R30 + σ1R31 −R31 +R21R∞)
9D2eR
2
1R
2∞
}1/2
. (3.26)
The advantage of incorporating information about the first moment is that the expression (3.26),
although more complex and costly than (3.24), provides a better indication of the release time (see
section 5 for additional comments on the results). Other time scale indicators can be similarly
defined by the natural extension of (3.25) to higher moments, but because of their increasingly
complicated form, they likely have limited practical use.
2Note that evaluating either u0(r), u1(r) or ue(r) allows the area under the c˜0(t) curve between t = 0 and t→∞
to be calculated for any value of r, which may also be of practical interest.
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4 Estimating the release time using high order moments
The characteristic timescales, t
(1)
c (3.24) or t
(2)
c (3.26), provide an indicator for, not an estimate of,
the release time of the capsule. In this section, we present an asymptotic estimate of the release
time defined as the time tr > 0 satisfying:
c˜0(tr) = ε, (4.1)
where ε is a small specified tolerance (see Figure 2b). In other words, tr measures the time taken
for the capsule to be depleted within a small tolerance. Since c˜0(t) monotonically decreases from
one to zero, tr is unique for a given choice of ε. Under this definition, the release time is not an
absolute concept, but dependent on the desired level of accuracy required to measure a complete
depletion.
To derive the asymptotic estimate of the release time, we extend to multi-layer diffusion in
spherical coordinates previous work by Carr [18], which focussed on monolayer diffusion in Cartesian
coordinates. At r = 0, the analytical solution to the drug diffusion model (2.1)–(2.10) possesses the
following functional form [8]:
c˜0(t) =
∞∑
j=0
γje
−tβj , 0 < β0 < β1 < β2 < . . . , (4.2)
where γj and βj are constants. It follows then that the long time behaviour of the concentration is
exponentially decreasing:
c˜0(t) ∼ γ0e−tβ0 , as t→∞. (4.3)
Combining Eqs (4.1) and (4.3) gives the following asymptotic estimate of the release time3:
tr ∼ ln(γ0/ε)
β0
. (4.4)
The formula (4.4) requires knowledge of γ0 and β0, which are related to the dominant eigenvalue
and eigenfunction pair of the underlying Sturm-Liouville problem [8]. Alternatively, γ0 and β0 can
be calculated by using appropriate temporal moments of the concentration as we now describe.
Define the kth temporal moment4:
ui,k(r) =
1
C0
∫ ∞
0
tkci(r, t) dt, (4.5)
where the first subscript indicates the layer (i = 0, 1, ..., e) and the second subscript denotes the kth
moment (k = 0, 1, . . .). Combining Eqs (4.2) and (4.5) and carrying out the integration yields:
u0,k(0) =
∞∑
j=0
k!γj
βk+1j
. (4.6)
Since β0 < βj for all j = 1, 2, . . ., we have the following asymptotic relation for the higher moments
[18]:
u0,k(0) ∼ k! γ0
βk+10
, as k →∞. (4.7)
3To guarantee tr > 0, the condition ε < γ0 is required.
4Under this definition the functions ui(r) defined in Eq (3.2) can be thought as the zeroth temporal moment, i.e.,
ui,k(r) with k = 0.
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Evaluating Eq (4.7) at k and k − 1 and solving the resulting algebraic system for γ0 and β0 gives:
γ0 =
u0,k(0)
k!
(
k u0,k−1(0)
u0,k(0)
)k+1
, β0 =
k u0,k−1(0)
u0,k(0)
. (4.8)
Finally, substituting Eq (4.8) into Eq (4.4) yields the following asymptotic estimate of the release
time:
tr ∼ u0,k(0)
ku0,k−1(0)
ln
[
u0,k(0)
k! ε
(
ku0,k−1(0)
u0,k(0)
)k]
=: t∗r , (4.9)
where the superscript (∗) is used to signify that t∗r is an asymptotic estimate of tr. Due to Eq (4.7),
the expectation is that t∗r becomes more accurate as k increases [18]. The attraction of the formula
for t∗r is that the moment expressions appearing in Eq (4.9) can be calculated without computing
the full transient solution ci(r, t), which appears in the definition (4.5). This is achieved by deriving
a similar boundary value problem to the one satisfied by ui(r) (or, equivalently ui,0(r)) given in Eqs
(3.6)–(3.12). Applying the linear operator L in Eq (3.4) to Eq (4.5) and utilising Eqs (2.1)–(2.3)
yields:
Di
r2
d
dr
(
r2
dui,k
dr
)
=
1
C0
∫ ∞
0
tk
∂ci
∂t
dt. (4.10)
Integrating by parts and noting that ci(r, t) → 0 exponentially as t → ∞ produces the following
differential equation for ui,k−1(r):
Di
r2
d
dr
(
r2
dui,k
dr
)
= −kui,k−1, (4.11)
involving the (k − 1)th moment, ui,k−1(r). Similar boundary and interlayer conditions to those in
Eqs (3.6)–(3.12) apply [14] giving the following boundary value problem for the kth moment:
D0
r2
d
dr
(
r2
du0,k
dr
)
= −ku0,k−1, r ∈ (0, R0) (4.12)
Di
r2
d
dr
(
r2
dui,k
dr
)
= −kui,k−1, r ∈ (Ri−1, Ri), i = 1, . . . , n, (4.13)
De
r2
d
dr
(
r2
due,k
dr
)
= −kue,k−1, r ∈ (Rn, R∞), (4.14)
du0,k
dr
= 0, r = 0, (4.15)
ui,k = σiui+1,k, Di
dui,k
dr
= Di+1
dui+1,k
dr
, r = Ri, i = 0, 1, . . . , n− 1, (4.16)
Dn
dun,k
dr
= De
due,k
dr
, De
due,k
dr
= P (σnue,k − un,k), r = Rn, (4.17)
ue,k = 0, r = R∞. (4.18)
The release time is computed iteratively by solving the sequence of boundary value problems (4.12)–
(4.18) for increasing values of k [18, 20]. First, an initial estimate of t∗r is calculated using k = 1
in Eq (4.9) by solving Eqs (4.12)–(4.18) with k = 1 and by using the zeroth order moment ui,0(r)
computed previously (Section 3) in the right-hand side of Eqs (4.12)–(4.14). Next, an improved
estimate of t∗r is computed using k = 2 in Eq (4.9) by solving Eqs (4.12)–(4.18) with k = 2 and
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using the previously computed moment ui,1(r) in the right-hand side of Eqs (4.12)–(4.14). The
process repeats over k until the value of t∗r converges sufficiently to an accurate estimate of tr as
defined in Eq (4.1). We remark that numerically solving the system (4.12)–(4.18) is computationally
inexpensive, since the coefficient matrix that arises from spatial discretisation of the boundary value
problem remains unchanged throughout the iterations and only needs to be factorized once, with
only the right-hand side of Eqs (4.12)–(4.14) changing with k.
5 Results and discussion
In this section, we apply the characteristic timescale of Section 3 and the release time estimate of
Section 4 to several test cases. For all our numerical experiments we consider the drug diffusion
model (2.1)–(2.10) with n = 1 (core-shell model) and the following base values for the geometrical
and physical parameters [8, 9, 21]:
R0 = 1.5 · 10−3 m, R1 = 1.7 · 10−3 m, R∞ = 30 · 10−3 m, σ0 = σ1 = 1, (5.1)
D0 = 30 · 10−11 m2s−1, D1 = 5 · 10−11 m2s−1, De = 30 · 10−11 m2 s−1, P →∞. (5.2)
Using this set of parameter values, we first investigate the convergence behaviour of the asymptotic
estimate of the release time, t∗r (4.9), for increasing values of k. In Table 1, we report the value of
t∗r and c˜0(t∗r) for k = 1, . . . , 14 and ε = 10−4, 10−5, 10−6. These results show that t∗r is converging to
a highly accurate estimate of the release time, with limk→∞ c˜0(t∗r) close to the prescribed value of
ε in all three cases. For the two smaller values of ε, limk→∞ c˜0(t∗r) is closer to the specified value of
ε because the one-term approximation (4.3) becomes more accurate for larger values of t. For this
parameter set, the release time estimate converges to the second by k = 12 for all three values of ε.
ε = 10−4
k t∗r c˜0(t∗r)
1 02:06:22:59 7.2152 · 10−4
2 07:23:03:31 8.6792 · 10−5
3 07:21:39:42 8.8261 · 10−5
4 07:14:19:34 9.6411 · 10−5
5 07:11:49:55 9.9360 · 10−5
6 07:11:02:47 1.0031 · 10−4
7 07:10:48:25 1.0060 · 10−4
8 07:10:44:09 1.0069 · 10−4
9 07:10:42:54 1.0071 · 10−4
10 07:10:42:33 1.0072 · 10−4
11 07:10:42:27 1.0072 · 10−4
12 07:10:42:25 1.0072 · 10−4
13 07:10:42:25 1.0072 · 10−4
14 07:10:42:25 1.0072 · 10−4
ε = 10−5
t∗r c˜0(t∗r)
02:22:53:05 4.8197 · 10−4
13:02:30:33 2.0023 · 10−5
15:11:32:11 1.0190 · 10−5
15:14:06:10 9.8849 · 10−6
15:13:37:58 9.9401 · 10−6
15:13:18:53 9.9777 · 10−6
15:13:11:17 9.9926 · 10−6
15:13:08:41 9.9977 · 10−6
15:13:07:52 9.9994 · 10−6
15:13:07:37 9.9999 · 10−6
15:13:07:32 1.0000 · 10−5
15:13:07:31 1.0000 · 10−5
15:13:07:31 1.0000 · 10−5
15:13:07:31 1.0000 · 10−5
ε = 10−6
t∗r c˜0(t∗r)
03:15:23:12 3.5016 · 10−4
18:05:57:35 4.6400 · 10−6
23:01:24:40 1.1822 · 10−6
23:13:52:46 1.0199 · 10−6
23:15:26:02 1.0013 · 10−6
23:15:34:58 9.9953 · 10−7
23:15:34:10 9.9969 · 10−7
23:15:33:14 9.9988 · 10−7
23:15:32:50 9.9996 · 10−7
23:15:32:41 9.9999 · 10−6
23:15:32:38 1.0000 · 10−6
23:15:32:37 1.0000 · 10−6
23:15:32:37 1.0000 · 10−6
23:15:32:37 1.0000 · 10−6
Table 1: Convergence of the asymptotic estimate of the release time t∗r (4.9) for increasing values of the index
k applied to the drug diffusion model (2.1)–(2.10) with a single hydrogel layer (n = 1) and the physical param-
eters (5.1)–(5.2). The value of t∗r is calculated using three different choices for ε and is displayed in the format
days:hours:minutes:seconds.
We now investigate the sensitivity of t∗r when varying the outer radius of the capsule, R1, the
mass transfer coefficient at the external coating, P , the diffusivity in the core, D0, and the diffusivity
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(a) (e)
(b) (f)
(c) (g)
(d) (h)
Figure 3: (a)–(d) Profiles of the dimensionless concentration at the centre of the capsule, c˜0(t), over time showing
the effect of varying (a) the outer radius of the capsule (R1); (b) the mass transfer coefficient at the external coating
(P ); (c) the diffusivity in the core (D0); and (d) the diffusivity in the hydrogel layer (D1). (e)–(f) Sensitivity of the
characteristic timescales, t
(1)
c and t
(2)
c , and release time, t
∗
r (calculated using k = 15 and ε = 10
−4), when varying (e)
R1; (f) P ; (g) D0; and (h) D1. When varying a parameter all other variables are held fixed at the values given in Eqs
(5.1)–(5.2). All results are based on the drug diffusion model (2.1)–(2.10) with a single hydrogel layer (n = 1) and
the baseline parameter values in Eqs (5.1)–(5.2) (cf. Table 2).
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Varying R1
Case 1 2 3 4 5 6
R1 [m] 1.52 · 10−3 1.74 · 10−3 1.99 · 10−3 2.28 · 10−3 2.62 · 10−3 3.00 · 10−3
t
(1)
c [h] 1.04 1.48 1.86 2.20 2.49 2.74
t
(2)
c [h] 5.32 6.03 6.80 7.61 8.45 9.32
t∗r [h] 177.78 178.91 180.40 182.39 185.03 188.55
Varying P
Case 7 8 9 10 11 12
P [m s−1] 1.00 · 10−8 2.51 · 10−8 6.31 · 10−8 1.58 · 10−7 3.98 · 10−7 1.00 · 10−6
t
(1)
c [h] 12.23 5.72 3.13 2.10 1.69 1.52
t
(2)
c [h] 21.86 12.73 8.77 7.08 6.39 6.11
t∗r [h] 214.19 191.96 183.86 180.74 179.51 179.03
Varying D0
Case 13 14 15 16 17 18
D0 [m
2 s−1] 3.00 · 10−11 7.54 · 10−11 1.89 · 10−10 4.75 · 10−10 1.19 · 10−9 3.00 · 10−9
t
(1)
c [h] 4.54 2.45 1.62 1.29 1.16 1.10
t
(2)
c [h] 11.35 7.54 6.22 5.74 5.55 5.48
t∗r [h] 183.16 180.17 178.99 178.53 178.34 178.27
Varying D1
Case 19 20 21 22 23 24
D1 [m
2 s−1] 5.00 · 10−12 1.26 · 10−11 3.15 · 10−11 7.92 · 10−11 1.99 · 10−10 5.00 · 10−10
t
(1)
c [h] 5.83 2.88 1.70 1.23 1.05 0.97
t
(2)
c [h] 15.36 8.70 6.41 5.63 5.34 5.23
t∗r [h] 189.86 182.33 179.41 178.26 177.81 177.63
Table 2: Sensitivity of the characteristic timescales, t
(1)
c and t
(2)
c , and release time, t
∗
r with ε = 10
−4, when varying
the outer radius of the capsule (R1); the mass transfer coefficient at the external coating (P ); the diffusivity in the
core (D0); and the diffusivity in the hydrogel layer (D1). When varying a parameter all other parameters are held
fixed at the values given in Eqs (5.1)–(5.2). All results are based on the drug diffusion model (2.1)–(2.10) with a
single hydrogel layer (n = 1). Values of R1, P , D0, D1 are displayed to three significant figures while values of t
(1)
c ,
t
(2)
c and t
∗
r are reported to two decimal places (cf. Figure 3).
in the hydrogel layer, D1, about the base values given in Eqs (5.1)–(5.2). Each of the parameters,
R1, P , D0 and D1, are varied one at a time holding the other three parameters fixed at the values
given in Eqs (5.1)–(5.2). We consider six logarithmically-spaced values of R1 between 1.515 · 10−3
and 3 · 10−3, P between 10−8 and 10−6, D0 between 3 · 10−11 and 3 · 10−9 and D1 between 5 · 10−12
and 5 · 10−10. In total, there are 24 test cases as labelled in Table 2. For all simulations, the release
time estimate t∗r (4.9) is calculated with k = 15 and ε = 10−4. Results in Figures 3(a)–(d) show the
effect that varying each parameter has on the temporal profile of the dimensionless concentration
at the centre of the capsule, c˜0(t). These curves demonstrate that, over the specified ranges of each
parameter, the time required for c˜0(t) to approach zero increases for increasing values of R1 and
decreasing values of P , D0 and D1. This translates to larger values of t
∗
r for increasing values of R1
and decreasing values of P , D0 and D1 (holding all other parameters fixed) as confirmed in Figures
3(e)–(h) and Table 2.
An interesting exercise is to determine how well the characteristic timescales, t
(1)
c and t
(2)
c ,
indicate the value of the release time. To explore this, we plot t
(1)
c and t
(2)
c versus R1, P , D0 and
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D1 in Figure 3(e)–(h) together with the corresponding values of the release time estimate t
∗
r . The
values of t
(1)
c and t
(2)
c are quite different from each other and differ considerably from t∗r . However,
this is not surprising because, as already mentioned, the goal of t
(1)
c and t
(2)
c is not to estimate the
release time but rather provide a cheap way to rank different capsule configurations in terms of
release time. Evident from these results is that both t
(1)
c and t
(2)
c follows the same general trend as
t∗r , that is, both increase with R1 and decrease with P , D0 and D1. As the c˜0(t) curves in Figures
3(a)–(d) do not intersect, we are guaranteed that a smaller value of t
(1)
c implies a smaller value of
t∗r , as confirmed in Figures 3(e)–(h). An equivalent guarantee is true for t
(2)
c . Comparing across
all 24 test cases listed in Table 2, we see that Case 24 gives rise to both the smallest characteristic
timescales and release time while Case 7 yields both the largest ones.
The above results seem to indicate that the characteristic timescale always provides a useful
indication of the release time. However, this is not necessarily true and caution is required when
using either t
(1)
c (3.24) or t
(2)
c (3.26) as an indicator of the release time of different capsule config-
urations. For example, consider two configurations A and B, where configuration A has physical
parameters (5.1)–(5.2) except with P = 5 · 10−8 m s−1 while configuration B has physical param-
eters (5.1)–(5.2) except with P = 5 · 10−8 m s−1 and R1 = 2.2 · 10−3 m. In this case, the value of
t
(1)
c is larger for configuration A despite the value of t∗r (calculated using ε = 10−4 and k = 15)
being smaller (see caption of Figure 4 for the numerical values). In Figure 4, we also see that the
dimensionless concentration at the centre of the capsule c˜0(t) for configurations A and B intersect,
meaning that a smaller value of t
(1)
c is not guaranteed to produce a smaller release time (as pointed
out in Section 3). Conversely, the value of t
(2)
c correctly correlates with t∗r . Here, the second term
in Eq (3.25) is larger for configuration B due to its heavier tail, which causes the value of t
(2)
c to be
larger for configuration B than for configuration A, consistent with t∗r (see caption of Figure 4 for
the numerical values).
Figure 4: Profile of the dimensionless concentration at the centre of the capsule, c˜0(t), for two configurations of the
drug diffusion model (2.1)–(2.10), both with a single hydrogel layer (n = 1). Configuration A has physical parameters
(5.1)–(5.2) except with P = 5 · 10−8 m s−1 while configuration B has physical parameters (5.1)–(5.2) except with
P = 5 · 10−8 m s−1 and R1 = 2.2 · 10−3 m. For configuration A, t(1)c = 3.58 h, t(2)c = 9.48 h and t∗r = 185.23 h while for
configuration B, t
(1)
c = 3.40 h, t
(2)
c = 10.37 h and t
∗
r = 190.45 h.
6 Conclusions
Polymer capsules, pellets, tablets, layer-by-layer vehicles and other micro-engineered drug releasing
implants are attracting a great deal of attention for their potential use for therapeutic applications.
The design of these novel drug delivery systems poses major challenges, such as the unknown
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significance of process parameters. Specifically, modelling and computational tools are provided to
assist in the development of drug-release devices that can control the time to establish a steady-state
flux or to deliver at a desired rate. The performance of a composite microcapsule can be sensibly
enhanced if the release mechanism is understood and an appropriate mathematical model is used
to characterize the releasing ability of the system. In this study, novel approaches to characterize
and estimate the release time of diffusion problems from spherical multi-layer capsules are proposed
under a limited number of physical assumptions. The method is based on the linearity of a pure
diffusive system, that holds or dominates in most circumstances. No explicit solution of the diffusion
problem is required; instead temporal moments of the drug concentration versus time curve at the
centre of the capsule are used to derive analytical expressions that provide a priori quantitative
indication of the drug release time. The proposed methodology, which combines in just one quantity
the relevant geometrical and physical parameters, provides a simple tool to measure microcapsule
dynamic performance.
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